Ascendia

  MARKET NEWS

Sanara MedTech Inc. Announces Exclusive License & Distribution Agreement With & Minority Investment in Biomimetic Innovations Ltd
ArriVent BioPharma Enters Exclusive License With Lepu Biopharma for an Antibody Drug Conjugate for the Treatment of Gastrointestinal Cancers
IMMvention Therapeutix Enters Strategic Collaboration With Novo Nordisk to Develop Oral Therapies
Silo Pharma Advances Intellectual Property Portfolio With Provisional Patent Filing for PTSD Treatment
Artax Biopharma Achieves Clinical Validation of First-in-Class Oral Nck Modulator for Autoimmune Disease in Phase 2a Study
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
Bluejay Therapeutics Receives FDA Breakthrough Therapy Designation for Brelovitug for the Treatment of Chronic Hepatitis Delta
Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination With GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma
Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 With Trabectedin in Certain Sarcomas

  EXPERT CONTENT & RESOURCES

CLINICAL TRIALS - Need for Accessibility to Meet FDA Guidance for Decentralized Trials

CLINICAL TRIALS - Need for Accessibility to Meet FDA Guidance for Decentralized Trials

Neil Vivian believes advances in electronic data collection and analysis are helping to make DCTs more accessible to broader and more diverse patient populations. Further innovations, particularly in artificial intelligence technology, are expected to accelerate these trends.  

DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products

DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products

Jeremy Guo, Senior Vice President at WuXi Biologics, and colleagues explain that many factors need to be taken into account when producing a Drug-Device Combination Product from development testing to fill/finish and assembly.

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Gaelic Laboratories today announces its new website, which contains details about this world-class Beta-Lactam (penicillin) manufacturer’s….

  FEATURED EDITORIAL

  COMPANY PROFILE

Mikart’s 45+ years of experience in oral solid and nonsterile oral liquid dosage forms and specialization in pediatric, geriatric, and controlled-substance make us the ideal contract development and manufacturing organization partner — from formulation development through commercialization. We value long-lasting relationships and a personalized approach; bringing both the reliability and flexibility to meet your needs and exceed your expectations. For the solid foundation and flexible solutions to bring your product to life, choose Mikart. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR - Enabling Upstream Intensified Bioprocessing

WEBINAR - Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while reducing footprint, costs, and timelines for manufacturing. The higher cell densities generated by….

WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing

WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing

Join us for an upcoming webinar that delves into a crucial issue in the pharmaceutical industry. Recent research has revealed a surprising fact: the pharmaceutical sector has a larger carbon footprint than even the automotive industry, especially when we consider the entire supply chain’s impact on

  WHITEPAPERS & WEBINARS

Technical Brief: Mucoadhesive Polymers in Pharmaceutical Formulations

Technical Brief: Mucoadhesive Polymers in Pharmaceutical Formulations

Mucoadhesion Matters

And so does your choice of mucoadhesive polymer.

This technical brief will cover the use of polymers in a variety of dosage forms (buccal/sublingual tablets, liquid, semi-solid formulations, and oral care products) to impart mucoadhesion. The basic mechanism …

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

Honeywell Aclar® thermoformable film enables pharmaceutical and medical device companies to achieve their sustainability commitments.

Aclar® film not only delivers a high moisture barrier to protect medicines, but it also reduces pack size, reduces waste, and reduces carbon emissions, compared

…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 29 – Bioavailability
February 5 – Analytical Testing